Suitable Docking Protocol for the Design of Novel Coumarin Derivatives with Selective MAO-B Effects
Open Access
- 30 June 2021
- journal article
- Published by Universitas Muhammadiyah Palangkaraya in Journal of Molecular Docking
- Vol. 1 (1), 40-47
- https://doi.org/10.33084/jmd.v1i1.2357
Abstract
Recently, the application of molecular docking is drastically increasing due to the rapid growth of resolved crystallographic receptors with co-crystallized ligands. However, the inability of docking softwares to correctly score the occurred interactions between ligands and receptors is still a relevant issue. This study examined the Pearson’s correlation coefficient between the experimental monoamine oxidase-B (MAO-B) inhibitory activity of 44 novel coumarins and the obtained GOLD 5.3 docking scores. Subsequently, optimization of the docking protocol was carried out to achieve the best possible pairwise correlation. Numerous modifications in the docking settings such as alteration in the scoring functions, size of the grid space, presence of active waters, and side-chain flexibility were conducted. Furthermore, ensemble docking simulations into two superimposed complexes were performed. The model was validated with a test set. A significant Pearson’s correlation coefficient of 0.8217 was obtained for the latter. In the final stage of our work, we observed the major interactions between the top-scored ligands and the active site of 1S3B.Keywords
This publication has 30 references indexed in Scilit:
- Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of InhibitorsMolecules, 2021
- Rutin as promising drug for the treatment of Parkinson’s disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studiesMolecular Simulation, 2019
- Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s diseaseJournal of Neural Transmission, 2018
- Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapyJournal of Neural Transmission, 2018
- Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s diseaseJournal of Neural Transmission, 2018
- Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson’s Disease ModelJournal of Molecular Neuroscience, 2017
- Computational methods in drug discoveryBeilstein Journal of Organic Chemistry, 2016
- In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitorsEuropean Journal of Medicinal Chemistry, 2015
- Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A2A Receptors for the Treatment of Parkinson's DiseaseJournal of Young Pharmacists, 2012
- Structure of human monoamine oxidase B, a drug target for the treatment of neurological disordersNature Structural & Molecular Biology, 2001